Navigation Links
The effect of treatment with antibiotics and vaccination against Q fever in sheep
Date:5/30/2012

Scientists at Neiker-Tecnalia, the Basque Institute for Agricultural Research and Development, have evaluated the effect of treatment with antibiotics and vaccination in controlling Q fever in sheep flocks. This disease mainly causes abortions, although it can also lead to premature births, low weight and weakness in newborn lambs. The control of this disease is of great importance in animal production, as it spreads easily among the animals and causes significant economic losses, and mainly because it can be transmitted to people in contact with infected livestock.

Q fever is a zoonotic disease one that animals can transmit to humans spread all over the world and caused by the bacteria Coxiella burnetii. In animals it causes mainly reproductive problems. In people, Q fever can be asymptomatic or like a flu syndrome; however, in acute cases pneumonia and/or hepatitis can appear.

Neiker-Tecnalia's research has been focussed on sheep, since this species is one of the main reservoirs of infection in the Basque Country. The researchers found that 74% of the flocks of sheep in the Basque Autonomous Community (region) had at least one animal with Coxiella burnetii antibodies. Presence of antibodies indicates that the animal has been in contact with the bacteria, but it does not mean that it has necessarily developed Q fever. In the case of goats herds the percentage of seroprevalence was 45%; and in cattle herds, 43%.

The first method used to control Q fever in naturally infected flocks was based on the application of the antibiotic oxytetracycline. The researchers gave the antibiotic to pregnant ewes at 100 and 120 days of gestation, and abortion rate was reduced to levels lower than 4%. However, oxytetracycline did not prove to be effective in reducing the infection nor the number of bacterial shedding. So Neiker-Tecnalia is proposing that a greater research effort has to be done in this field of veterinary medicine, since there are few antibiotics authorized for sheep that are effective against intracellular bacteria like Coxiella burnetii.

Vaccination, a promising method of control

The use of an inactivated vaccine to control the disease offered more promising results. The vaccine Coxevac was used and its effectiveness was proven in the short (1 year) and long term (4 years). No immediate effects were noticed during the first year following vaccination, because the flocks studied had a high percentage of infected animals. However, with routine annual vaccinations it was possible to gradually reduce the infection until its disappearance after four years of vaccination.

The vaccine was beneficial in controlling abortions which, after the first year of vaccination, were significantly reduced (<2%). Q fever is responsible for abortion rates between approximately 6% and 10% of the ewes in an infected flock.

After four years of vaccination, the absence of the infection in the animals did not necessarily mean that the bacteria Coxiella burnetii had been eradicated on the sheep flock, since this bacterium is very persistant in the environment, and it remains present in sheep premises (surfaces, floor, aerosols) for long periods of time. So Neiker-Tecnalia recommends that after an outbreak of Q fever in a sheep flock, vaccination should be implemented for a period of five years at least. It is very important that replacement lambs are immunised against the bacterium when they reach three months of age.

Means of eliminating Coxiella burnetti

Neiker-Tecnalia scientists found that the main Coxiella burnetti shedding routes in sheep are vaginal fluids and faeces; and to a lesser extent, milk. Bacterial shedding through milk is basically concentrated in the first month after lambing, while vaginal and faecal excretion is more prolonged in time. Bacterial excretion favours the generation of contaminated aerosols and the presence of the bacteria in the air in livestock premises, so there is a risk of Q fever transmission to susceptible animals, and to people in contact with infected animals.


'/>"/>

Contact: Irati Kortabitarte
i.kortabitarte@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related biology news :

1. Novel discovery by NUS scientists paves the way for more effective treatment of cancers
2. Lab tests show arthritis drug effective against global parasite
3. New evidence that many genes of small effect influence economic decisions and political attitudes
4. The gut could reveal effect of climate change on fish
5. WSU researchers say genes and vascular risk modify effects of aging on brain and cognition
6. Psychiatric medication effects on brain structure
7. Climatic effects of a solar minimum
8. First-of-its-kind study reveals surprising ecological effects of earthquake and tsunami
9. University of Nevada, Reno first to show transgenerational effect of antibiotics
10. Kinesiology team gets $975,000 Defense grant to study effects of heavy loads on soldiers
11. As deadly cat disease spreads nationally, MU veterinarian finds effective treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):
(Date:5/4/2016)... (PRWEB) , ... May 05, 2016 , ... ... is proud to support the National Stroke Association during National Stroke Awareness Month ... association’s Facebook and Twitter pages throughout the month. CereScan will donate $1 ...
(Date:5/4/2016)... , May 4, 2016  Bayer today announced ... compound Stivarga ® (regorafenib) tablets for the ... has met its primary endpoint of a statistically ... RESORCE, evaluated the efficacy and safety of regorafenib ... after treatment with sorafenib. The safety and tolerability ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... PBI-Gordon Corporation ... and Agricultural Sales. , Doug began his career at PBI-Gordon in February 1988, ... in a wide variety of roles, ranging from customer service to national product manager, ...
(Date:5/3/2016)... ... May 03, 2016 , ... Morf Media ... compliance training platform on mobile devices, today released a new interactive Food ... Medical Devices. The course is essential for owners or operators of places of ...
Breaking Biology Technology: